No phaseStatus unknown
A comparative study to determine outcome of Metformin and Myoinositol in women with Polyendocrine Metabolic Ovarian Syndrome
To compare the Efficacy, Safety, and Quality of Life Outcomes in Metformin and Myoinositol in women with Polyendocrine Metabolic Ovarian Syndrome,PMOS - NIL
- Sponsor
- Dayanand Medical College and Hospital
- Enrolment
- 100 planned
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Interventions
- Dr
- Registry
- CTRI-2026-08-115273
Full record on the Clinical Trials Registry – IndiaSource: WHO ICTRP, processed 14 September 2026
Primary outcomes
- 1.Mean change in HOMA IRTimepoint: measurement to be taken at the time of enrollment. follow up will be done at 3 months and at 6 months
History
Last registry update
Started
Registered